NCT03765294View on ClinicalTrials.gov

A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

November 5, 2019

Study Completion Date

November 5, 2019

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

ACT-541468

Film-coated tablet for oral use

DRUG

Placebo

Film-coated tablet for oral use

Trial Locations (1)

10117

Advanced Sleep Research, Berlin

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03765294 - A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter